Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab

NCT07363642 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Asthma

Interventions

DRUG: Tezepelumab

Sponsor

AstraZeneca